Financials
- Market Capitalization 1.73 B
- Employee 167
- Founded 2019
- CEO N/A
- Website www.zenasbio.com
- Headquarter Delaware, United States
- FIGI BBG01J1MG9D6
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-4.3
Fiyat/satışlar oranı
162.41
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2078 | IOVA Iovance Biotherapeutics, Inc. - Common Stock | 4.01 USD | -0.74% | -3.14% | -2.67% | +112.17% | 1.79 B USD | ||
| 2085 | AAPG Ascentage Pharma Group International - American Depository Shar | 19.02 USD | -3.06% | +1.77% | +5.84% | -23.92% | 1.78 B USD | ||
| 2103 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.27 USD | -0.91% | -16.15% | -0.91% | -38.42% | 1.73 B USD | ||
| 2120 | FTRE Fortrea Holdings Inc. - Common Stock | 17.90 USD | +0.22% | +3.05% | +7.12% | +251.67% | 1.69 B USD |